Literature DB >> 8181366

Nebulized lidocaine in the treatment of refractory cough.

S Trochtenberg1.   

Abstract

A 52-year-old man with intractable cough refractory to standard therapy was treated successfully with chronic nebulized lidocaine. He has experienced no adverse effects from the lidocaine except for occasional mild dysphonia. Measured serum levels of lidocaine after treatment have never exceeded 4.0 mg/dl. This case shows prolonged therapy with nebulized lidocaine is a safe and effective treatment for refractory cough.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8181366     DOI： 10.1378/chest.105.5.1592

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  8 in total

1.  Comparison of lidocaine and bronchodilator inhalation treatments for cough suppression in patients with chronic obstructive pulmonary disease.

Authors:  C-F Chong; C-C Chen; H-P Ma; Y-C Wu; Y-C Chen; T-L Wang
Journal:  Emerg Med J       Date:  2005-06       Impact factor: 2.740

2.  Clinical expert guidelines for the management of cough in lung cancer: report of a UK task group on cough.

Authors:  Alex Molassiotis; Jaclyn A Smith; Mike I Bennett; Fiona Blackhall; David Taylor; Burhan Zavery; Amelie Harle; Richard Booton; Elaine M Rankin; Mari Lloyd-Williams; Alyn H Morice
Journal:  Cough       Date:  2010-10-06

3.  RSD931, a novel anti-tussive agent acting on airway sensory nerves.

Authors:  J J Adcock; G J Douglas; M Garabette; M Gascoigne; G Beatch; M Walker; C P Page
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

Review 4.  Cough . 2: Chronic cough in children.

Authors:  J C de Jongste; M D Shields
Journal:  Thorax       Date:  2003-11       Impact factor: 9.139

Review 5.  Targeting voltage gated sodium channels NaV1.7, Na V1.8, and Na V1.9 for treatment of pathological cough.

Authors:  Yukiko Muroi; Bradley J Undem
Journal:  Lung       Date:  2013-11-24       Impact factor: 2.584

6.  Impact of intubated vs. non-intubated anesthesia on postoperative diaphragmatic function: Results from a prospective observational study.

Authors:  Irene Steinberg; Agnese Bisciaio; Giulio Luca Rosboch; Edoardo Ceraolo; Francesco Guerrera; Enrico Ruffini; Luca Brazzi
Journal:  Front Physiol       Date:  2022-08-08       Impact factor: 4.755

Review 7.  The Prospect for Potent Sodium Voltage-Gated Channel Blockers to Relieve an Excessive Cough.

Authors:  M Brozmanova; N Pavelkova
Journal:  Physiol Res       Date:  2020-03-27       Impact factor: 1.881

Review 8.  Peripheral mechanisms II: the pharmacology of peripherally active antitussive drugs.

Authors:  D Spina; I McFadzean; F K R Bertram; C P Page
Journal:  Handb Exp Pharmacol       Date:  2009
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.